isomethyleugenol has been researched along with Duodenal Ulcer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kliasheva, RI; Panfilova, GA; Volkov, VE | 1 |
Andersson, S; Nylander, B | 1 |
Darnis, F; Streichenberger, G | 1 |
1 trial(s) available for isomethyleugenol and Duodenal Ulcer
Article | Year |
---|---|
[Quality of results obtained in digestive pathology by acting upon motor, secretory and hormonal phenomena at the same time].
Topics: Biliary Dyskinesia; Clinical Trials as Topic; Colonic Diseases, Functional; Delayed-Action Preparations; Drug Tolerance; Duodenal Ulcer; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Methylation; Parasympatholytics; Tropanes | 1973 |
2 other study(ies) available for isomethyleugenol and Duodenal Ulcer
Article | Year |
---|---|
[Nucleotide composition and the methylated cytosine level in the DNA from a cancerous stomach tumor].
Topics: 5-Methylcytosine; Adenocarcinoma; Base Composition; Cytosine; DNA, Neoplasm; Duodenal Ulcer; Gastric Mucosa; Humans; Male; Methylation; Middle Aged; Nucleotides; Stomach Neoplasms | 1980 |
Gastric secretory inhibition by two 16-methylated analogs of prostaglandin E2 given intragastrically to patients with duodenal ulcer disease.
Topics: Adult; Cobalt Radioisotopes; Depression, Chemical; Dose-Response Relationship, Drug; Duodenal Ulcer; Gastric Juice; Humans; Male; Methylation; Middle Aged; Pepsin A; Prostaglandins; Secretory Rate; Stimulation, Chemical; Vitamin B 12 | 1975 |